Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

HAE
Patient organisation

HAE

ChildrenImmune system disordersSkin and subcutaneous tissue disorders
Visit official website

About the organisation

HAE Junior is a Czech non-profit patient organization established in December 2019 by a group of parents in Prague. Its core mission is to improve the quality of life for children and young people suffering from Hereditary Angioedema (HAE), a rare and potentially life-threatening genetic condition. HAE Junior implements various projects such as educational workshops, inclusive scholarships, summer camps for the patient community, and awareness-raising exhibitions.

Areas of specialisation

Where this organisation focuses its support

Diseases & conditions
Angioedema
Therapeutic area
Immune system disordersSkin and subcutaneous tissue disorders
Age groups served
Children

Organisations in the same therapeutic area Partners active in Immune system disorders

Explore by therapeutic area →
← All patient organisationsIs this your organisation?
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

ClinicalTrials.eu

Every clinical trial in Europe, in plain language.

Explore the full ecosystem of clinical research in Europe.

Search trials

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).